NO981748L - Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette - Google Patents

Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette

Info

Publication number
NO981748L
NO981748L NO981748A NO981748A NO981748L NO 981748 L NO981748 L NO 981748L NO 981748 A NO981748 A NO 981748A NO 981748 A NO981748 A NO 981748A NO 981748 L NO981748 L NO 981748L
Authority
NO
Norway
Prior art keywords
well
new dna
protein
producing protein
producing
Prior art date
Application number
NO981748A
Other languages
English (en)
Norwegian (no)
Other versions
NO981748D0 (no
Inventor
Nobuaki Nakagawa
Hisataka Yasuda
Tomonori Morinaga
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of NO981748D0 publication Critical patent/NO981748D0/no
Publication of NO981748L publication Critical patent/NO981748L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO981748A 1996-08-19 1998-04-17 Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette NO981748L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規ｄｎａ及びそれを用いた蛋白質の製造方法
PCT/JP1997/002859 WO1998007840A1 (fr) 1996-08-19 1997-08-19 Nouveaux adn et procede de production de proteines a l'aide de ces derniers

Publications (2)

Publication Number Publication Date
NO981748D0 NO981748D0 (no) 1998-04-17
NO981748L true NO981748L (no) 1998-06-18

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981748A NO981748L (no) 1996-08-19 1998-04-17 Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette

Country Status (12)

Country Link
EP (1) EP0874045A1 (https=)
JP (1) JPH1057071A (https=)
KR (1) KR20000064276A (https=)
CN (1) CN1198776A (https=)
AU (1) AU718458B2 (https=)
CA (1) CA2235148A1 (https=)
FI (1) FI980853A7 (https=)
HU (1) HUP0001837A3 (https=)
NO (1) NO981748L (https=)
NZ (1) NZ330400A (https=)
WO (1) WO1998007840A1 (https=)
ZA (1) ZA977402B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
US6242213B1 (en) 1996-12-23 2001-06-05 Immunex Corporation Isolated DNA molecules encoding RANK-L
WO1999058674A2 (en) 1998-05-14 1999-11-18 Immunex Corporation Method of inhibiting osteoclast activity
KR100496063B1 (ko) 1997-04-15 2005-06-21 산쿄 가부시키가이샤 신규단백질 및 그 제조방법
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
EP0975754B2 (en) 1997-04-16 2016-01-06 Amgen Inc., Osteoprotegerin binding proteins and their receptors
WO1999015691A1 (en) 1997-09-24 1999-04-01 Snow Brand Milk Products Co., Ltd. Method for diagnosing bone dysbolism
HUP0104126A3 (en) 1998-10-28 2004-07-28 Sankyo Company Ltd Chuo Ku Remedies for bone metabolic errors
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
AU7720600A (en) * 1999-09-27 2001-04-30 Eli Lilly And Company Osteoprotegerin regulatory region
JP4921687B2 (ja) 2001-04-03 2012-04-25 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳中の破骨細胞分化抑制因子
MXPA03010747A (es) 2001-05-25 2004-03-02 Human Genome Sciences Inc Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral.
WO2003086289A2 (en) 2002-04-05 2003-10-23 Amgen Inc. Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
ZA977402B (en) 1999-02-18
EP0874045A4 (https=) 1998-11-18
CN1198776A (zh) 1998-11-11
FI980853L (fi) 1998-06-15
HUP0001837A2 (hu) 2000-09-28
AU3866197A (en) 1998-05-11
EP0874045A1 (en) 1998-10-28
CA2235148A1 (en) 1998-02-26
MX9803086A (es) 1998-11-29
AU718458B2 (en) 2000-04-13
JPH1057071A (ja) 1998-03-03
HUP0001837A3 (en) 2002-09-30
NO981748D0 (no) 1998-04-17
KR20000064276A (ko) 2000-11-06
FI980853A0 (fi) 1998-04-17
WO1998007840A1 (fr) 1998-02-26
FI980853A7 (fi) 1998-06-15
NZ330400A (en) 1999-05-28

Similar Documents

Publication Publication Date Title
NO981748L (no) Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette
Kreimeyer et al. DNA repair-associated ADP-ribosylation in vivo. Modification of histone H1 differs from that of the principal acceptor proteins.
KR970000808B1 (en) Human proapolipoprotein a-1 expression
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
BR0106682A (pt) Molécula de anticorpo, variante de molécula de anticorpo, anticorpo, composto, sequência de dna, vetor de clonagem ou de expressão, vetor de expressão de e. coli, célula hospedeira, processo para a produção da molécula de anticorpo, composição terapêutica ou diagnóstica, uso da molécula de anticorpo, vetorpdnabeng-g1, vetorptto(cdp870), e, polipeptìdeo
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
AU2002339458A1 (en) Sirna knockout assay method and constructs
DK338788A (da) Fremgangsmaade til transformering af celler
DE69840333D1 (de) 2-m übergang des zellzyklus
GB9722320D0 (en) Human cell cycle checkpoint proteins
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
AU3230797A (en) Dna encoding dp. 75 and a process for its use
WO1998006841A3 (en) Two human nsp-like proteins
WO1998011234A3 (en) Human protein kinases
Pettijohn Ordered and preferential initiation of ribosomal RNA synthesis in vitro
FR2814744B1 (fr) Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
Lanzendörfer et al. Structure and function of the DNA-dependent RNA polymerase of Sulfolobus
WO2000065062A3 (fr) Sequence genomique et polypeptides de pyrococcus abissy, leurs fragments et leurs utilisations
CA2327587A1 (en) Methods for treatment of haemophilia a patients using human anti-human fviii antibodies
Crawford et al. DNA sequence of the tryptophan synthase genes of Pseudomonas putida
WO2000024765A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
Biswas et al. DNA helicase associated with DNA polymerase. alpha.: Isolation by a modified immunoaffinity chromatography
Amblar et al. Purification and properties of the 5′-3′ exonuclease D10A mutant of DNA polymerase I from Streptococcus pneumoniae: a new tool for DNA sequencing
Katouzian-Safadi et al. Identification of the DNA-interacting sites of proteins: Microsequencing of the peptides cross-linked to 5-bromouracil substituted DNA
NZ512308A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof